China
Africa
Explore chapters and articles related to this topic
Published in Ronald M. Atlas, James W. Snyder, Handbook Of Media for Clinical Microbiology, 2006
Ronald M. Atlas, James W. Snyder
Use: For the cultivation, differentiation, and enumeration ofEnterococcus species based on starch hydrolysis and production of fluorescence. Bacteria that hydrolyze starch, such as Streptococcus bovis, appear as colonies surrounded by a clear zone. Bacteria that produce fluorescence, such as Streptococcus bovis and Enterococcus faecium, appear as colonies surrounded by a zone of bright bluish fluorescence when viewed under a long-wave UV lamp. Other bacteria, such as Enterococcus faecalis, En-terococcus avium, or Streptococcus equinus, do not hydrolyze starch or produce fluorescence.
Impact of a Gastrointestinal Stable Probiotic Supplement Bacillus coagulans LBSC on Human Gut Microbiome Modulation
Published in Journal of Dietary Supplements, 2021
Chiranjit Maity, Anil Kumar Gupta, PhD, Dina B. Saroj, Atul Biyani, Pratik Bagkar, Jayshree Kulkarni, Yogini Dixit
Among predominant families, several species were found to be abundant in IBS patients such as Prevotella copri, Chlamydia trachomatis, Prevotella massiliatimonensis, Catenibacterium mitsuokai, Escherichia coli, Enterococcus hirae, Streptococcus agalactiae, Lactobacillus delbrueckii, Lactobacillus mucosae, Streptococcus equinus, Streptococcus pyogenes, Streptococcus salivarius, Streptococcus suis, Holdemanella biformis, Collinsella aerofaciens, Streptococcus infantarius, Cronobacter sakazakii, Enterobacter cloacae, Enterococcus italicus and Enterobacter hormaechei.
Full-face augmentation using Tissuefill mixed with platelet-rich plasma: “Q.O.Fill”
Published in Journal of Cosmetic and Laser Therapy, 2019
Hyejeong Lee, Kichan Yoon, Munjae Lee
Fillers are one of the major tools for rejuvenation of the skin. The first FDA-approved filler for soft tissue augmentation was a solution of soluble collagen marketed by Collagen Corporation in 1983(10–12). Since 1996, HA has been used as a filling agent. HA is a glycosaminoglycan polysaccharide present in the human body. Nowadays, HA is produced by bacterial fermentation (Streptococcus equinus principally); there is no risk of animal-derived contamination. As HA has no species specificity, there is no need for skin testing (13).